Photosensitive Epilepsy & COVID-19
January 25, 2021
Photosensitive epilepsy is a type of stimulus-induced reflex epilepsy that affects 3-5% of the 2.7 million Americans living with epilepsy. Various preventative strategies exist to avoid stimulus-induced seizures, especially in regards to COVID-19, and should be tailored to the specific needs of the individual at the recommendation of the treating physician.
Learn about SYMPAZAN by Aquestive
August 7, 2020
For years, clobazam was only available in pills or liquids. Thanks to PharmFilm technology, SYMPAZAN is the only product to offer clobazam in a convenient film.
FDA Approves FINTEPLA® (fenfluramine) for the Treatment of Seizures Associated with Dravet Syndrome
July 1, 2020
FINTEPLA® significantly and substantially reduced convulsive seizure frequency in patients whose seizures were not adequately controlled on other medications, as observed in two phase 3 placebo-controlled clinical trials.
Disability Rights Maine - Client Assistance Program
June 3, 2020
The Client Assistance Program (CAP) is a federally funded program that provides information, assistance, and advocacy to people with disabilities who are applying for or receiving services under the Rehabilitation Act.
May 13, 2020
Resources provided by UCB
May 5, 2020
Information about VALTOCO® and how to access the nasal spray
March 15, 2020
A message from Biocodex on access to their rescue medication, Diacomit.